Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Basis Plan Evaluation

Basis plan evaluation presents the optimization results of the provided test data the value plan and the sales, distribution, production and procurement... [Pg.215]

The basis plan evaluation analyzes optimization volumes and value results across the considered planning horizon of 12 periods. First, solution times for the continuous products and the campaign problem are shown in table 31. [Pg.216]

Sales scenario evaluation considers the impact of sales prices, sales flexibility and elasticity on volumes and values. Initially, sales prices are varied starting from a basis plan and consider the impact on volumes and values shown in fig. 86. [Pg.226]

No adjuvant is licensed as a medicinal product in its own right, but only as a component of a particular vaccine. Therefore preclinical and toxicology studies need to be designed on a case-by-case basis to evaluate the safety profile of the adjuvant and adjuvant/ vaccine combination [60], Evaluation in preclinical studies is important for identifying the optimum composition and formulation process and also for allowing development of tests for quality control [61]. Data from these studies also helps plan protocols for subsequent clinical trials from which safety and efficacy in humans can be evaluated. [Pg.695]

The approved execution plan and schedule must remain unchanged and become the basis to evaluate project performance. When contractors say "I meet all my schedules," they sometimes mean "I met the last revision of all my schedules." Even if the working schedules must be revised as required to preserve their meaningfulness, contractors should never be allowed to change the original approved schedule. [Pg.228]

It is a common experience in synthetic chemistry that a truly optimal ordering of a synthetic route may not be possible in the planning stage, but may have to determined experimentally. The precise information necessary for the complete and unambiguous evaluation of each step in a possible synthesis is hardly ever available. Nonetheless it is clearly wise to try to optimize a synthetic plan on the basis of available information before the experimental approach begins. Such an effort may suggest certain preliminary or "model" experiments that can be helpful in the choice or refinement of a synthetic plan. It is also obviously desirable to devise and consider alternate or bypass paths for each problematic step of a synthetic sequence. [Pg.79]

For the reactions in question no term may be neglected and it was necessary to carefully plan the experimental program to facilitate evaluation of all five kinetic parameters. On the basis of the data below determine these parameters when the weak acid employed is acetic acid. [Pg.243]

The sample temperature is increased in a linear fashion, while the property in question is evaluated on a continuous basis. These methods are used to characterize compound purity, polymorphism, solvation, degradation, and excipient compatibility [41], Thermal analysis methods are normally used to monitor endothermic processes (melting, boiling, sublimation, vaporization, desolvation, solid-solid phase transitions, and chemical degradation) as well as exothermic processes (crystallization and oxidative decomposition). Thermal methods can be extremely useful in preformulation studies, since the carefully planned studies can be used to indicate the existence of possible drug-excipient interactions in a prototype formulation [7]. [Pg.17]

The Bureau of Competition and Policy Planning Staff of the Federal Trade Commission ( FTC ) submit this Citizen Petition to the Commissioner of Food and Drugs pursuant to 21 C.F.R. 10.25(a) and 10.30 concerning certain issues relating to patent listings in the FDA s Approved Dmg Produets with Therapeutic Equivalence Evaluations (the Orange Book ). We request that the FDA clarify these issues, on an expedited basis, via industry guidanee or other means that the FDA considers appropriate. [Pg.108]

Process owners must be capable to evaluate and interpret the effect of nonconformances and planned deviations on their systems. Process owners can evaluate the need and lead efforts for corrective or preventive action, ensuring adequate corrections and improvements are implemented. An effective QMS ensures deviations from approved processes are owned and adequately investigated by the process owner s and ultimately approved by their quality assurance counterpart. The knowledge of these events is the basis and foundation for the process owners to make a risk-based evaluation on whether or not process changes are required, documentation or training require modification, or continuous improvement efforts are warranted. [Pg.271]

Extent of Validation Depends on Type of Method On the one hand, the extent of validation and the choice of performance parameters to be evaluated depend on the status and experience of the analytical method. On the other hand, the validation plan is determined by the analytical requirement(s) as defined on the basis of customer needs or as laid down in regulations. When the method has been fully validated according to an international protocol [63,68] before, the laboratory does not need to conduct extensive in-house validation studies. It must only verify that it can achieve the same performance characteristics as outlined in the collaborative study. As a minimum, precision, bias, linearity, and ruggedness studies should be undertaken. Similar limited vahdation is required in cases where it concerns a fully validated method which is apphed to a new matrix, a well-established but noncol-laboratively studied method, and a scientifically pubhshed method with characteristics given. More profound validation is needed for methods pubhshed as such in the literature, without any characteristic given, and for methods developed in-house [84]. [Pg.762]

Purchasing specifications include not only performance data, materials, structural details, plot plan considerations, guarantees, etc., but also methods of bid evaluation, applicable unit costs, energy costs and amortization period. A good group of specifications will permit a true cost comparison of competitive towers on an installed, as well as on an operating, basis. Table 6.3 summarizes the normal specifications that should be considered. [Pg.158]


See other pages where Basis Plan Evaluation is mentioned: [Pg.216]    [Pg.216]    [Pg.436]    [Pg.280]    [Pg.146]    [Pg.55]    [Pg.613]    [Pg.402]    [Pg.8]    [Pg.398]    [Pg.104]    [Pg.2181]    [Pg.211]    [Pg.383]    [Pg.83]    [Pg.52]    [Pg.515]    [Pg.1444]    [Pg.258]    [Pg.480]    [Pg.26]    [Pg.8]    [Pg.213]    [Pg.92]    [Pg.106]    [Pg.108]    [Pg.372]    [Pg.624]    [Pg.638]    [Pg.229]    [Pg.48]    [Pg.288]    [Pg.697]    [Pg.88]    [Pg.218]    [Pg.320]    [Pg.40]   


SEARCH



Plan evaluation

Planning Basis

Planning evaluation

© 2024 chempedia.info